|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1991-5-24
|
|
pubmed:abstractText |
The effects of stable PGI analogue TTC-909 on CBF and glucose metabolism was studied in the chronic stage of cerebral ischaemia produced by occluding the distal MCA in SHRSP. Administration of TTC-909 (100 ng/kg/day during 7 days) prevented the development of ischaemic oedema and improved secondary metabolic derangement coupled to flow in postischaemic tissues, particularly in the ischaemic rim.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0065-1419
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
242-4
|
|
pubmed:dateRevised |
2009-11-11
|
|
pubmed:meshHeading |
pubmed-meshheading:2089907-Animals,
pubmed-meshheading:2089907-Brain,
pubmed-meshheading:2089907-Brain Ischemia,
pubmed-meshheading:2089907-Cerebrovascular Circulation,
pubmed-meshheading:2089907-Cerebrovascular Disorders,
pubmed-meshheading:2089907-Disease Susceptibility,
pubmed-meshheading:2089907-Epoprostenol,
pubmed-meshheading:2089907-Glucose,
pubmed-meshheading:2089907-Male,
pubmed-meshheading:2089907-Rats,
pubmed-meshheading:2089907-Rats, Inbred SHR,
pubmed-meshheading:2089907-Tissue Distribution
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Post-ischaemic treatment with the prostacycline analogue TTC-909 reduces ischaemic brain injury.
|
|
pubmed:affiliation |
Department of Neurosurgery, National Defense Medical College, Saitama, Japan.
|
|
pubmed:publicationType |
Journal Article
|
